GLUC 最新10-Q变化
将 GLUC 最新的定期申报(10-K/10-Q)与上一份同类型申报逐章节对比:每个章节新增/删除的段落数与原文摘录。全部为确定性文本对比——无相似度评分、无方向判断、非投资建议。
对比:10-Q · 2017-11-14 与上一份 10-Q · 2017-08-21
| 章节 | 结果 | 新增 | 删除 | 微调 | 未变 |
|---|---|---|---|---|---|
| 管理层讨论与分析 | 文字有新增/删除 | +13 | −12 | ~21 | 11 |
| 市场风险(第3项) | 无段落级文字变化 | 0 | 0 | 0 | 1 |
| 控制与程序 | 文字有新增/删除 | 0 | 0 | ~1 | 3 |
| 法律诉讼 | 无段落级文字变化 | 0 | 0 | 0 | 1 |
计数单位为段落;"新增/删除"指相对上一份文件新增/删除的文字,不含方向或好坏判断。
未列出(无法可靠提取或缺失):风险因素、其他信息
代表性摘录
每个章节最多 5 条、每条约 300 字符的原文摘录,直接来自两份 SEC 文件。
管理层讨论与分析
相对上期新增的文字 · 来源:10-Q · 2017-11-14
Subsequent to the period ended September 30, 2017, on October 19, 2017, the Company entered into an agreement with Amazon to enable Amazon customers to purchase Glucose Health®.
Our principal business strategy for the next twelve months will be to introduce and manufacture new Glucose Health® products including flavor and packaging options; to implement marketing and sales initiatives; and to earn significant revenues and profits, of which there is no guarantee. Our sales i…
We incurred total operating expenses of $18,358 compared to $52,932 for the three-month periods ended September 30, 2017 and 2016, respectively. Our decreased operating expenses in the 2017 period is due to decreases in advertising and promotion fees, professional fees and stock based compensation.
We incurred total interest expense of $5,720 compared to $105,263 for the three-month periods ended September 30, 2017 and 2016, respectively. Our decreased total interest expense in the 2017 period is due to our prior year expensing of the beneficial conversion discount of our convertible notes pay…
During the three-month period ended September 30, 2017, the Company deemed an account payable uncollectable pursuant to a legal opinion for a gain of $19,854.
相对上期删除的文字 · 来源:10-Q · 2017-08-21
Our principal business strategy for the next twelve months will be to implement marketing and sales initiatives and earn significant revenues from the manufacture and distribution of our Glucose Health® product. Our sales initiatives will be focused upon securing repeat purchase orders for Glucose H…
For the three month period ended June 30, 2017, we had total operating expenses of $17,697 as compared to total operating expenses of $15,313 for the three month period ended June 30, 2016. The increase of $2,384 or 16%, in our operating expenses between the two periods is due to a $594 increase in …
For the three month period ended June 30, 2017, we had total interest expense of $5,096 as compared to total interest expense of $93,402 for the three month period ended June 30, 2016. The decrease of $88,306 or 96%, is due to the prior year expensing of the discount on convertible notes payable. Th…
During 2017, the Company settled accounts payable for a gain of $38,277.
For the period ended June 30, 2017, we had net income of $49,258 or $0.01 per share as compared with a net loss of $87,370 or $0.03 per share for the period ended June 30, 2016. The increase in net income is mainly attributable to the decrease in interest expense and the gain on the settlement of ac…
如何读 10-Q 的风险因素(第 1A 项)
10-Q 的风险因素章节有三种常见形态,本页按其一分类展示:
- 指向(pointer) — 公司仅声明"无重大变化"并指向年度 10-K 的完整风险因素;本季没有自己的风险文本可对比。
- 部分更新(partial) — 公司写明"除下述外无重大变化",只更新部分风险;摘录展示的正是本季新增的内容。
- 全文重述(restated) — 本季重新给出完整风险因素。若上一季只是"指向",则无法逐段对比,本页会将其标为"本季全文重述"。
这只是对文件结构的客观描述,不构成对风险高低的判断。
数据来自 SEC EDGAR 两份申报文件的文本级对比 · 确定性计算(无 AI 生成内容)· 仅供参考 · 非投资建议